Search
-
Searchresult: Donations due to a bereavement
Your contact person Alexandra Mayfarth Office of Development German Cancer Research Center +49 6221 42-2848 trauerfall@dkfz.de Further information FAQ: Häufig gestellte Fragen…
-
Searchresult: Bequest
You can rely on this: Organization of the funeral (at your request also in the Ruheforst, Friedwald or another forest cemetery), if you have not already arranged this yourself Completion of all…
-
Searchresult: Inheritance Donation
Your contact person Our contact person will be happy to talk to you personally - also in your area. Please feel free to contact us. Michaela Jacobsohn Office of Development German Cancer…
-
Searchresult: Synthesis_of_Clionastatin_B.pdf
Asymmetric Total Synthesis of Clionastatins A and B H PhPh N B Wei Ju, Xudong Wang, Hailong Tian, and Jinghan Gui* (R)-Me-CBS O J. Am. Chem. Soc. 2021, 143, 13016−13021 O Me 4. Me 2. KHMDS,…
Document -
Searchresult: Synthesis_of_Clionastatin_B_Solution.pdf
Asymmetric Total Synthesis of Clionastatins A and B H PhPh N B Wei Ju, Xudong Wang, Hailong Tian, and Jinghan Gui* (R)-Me-CBS O J. Am. Chem. Soc. 2021, 143, 13016−13021 O Me 4. Me OMOM 1.…
Document -
Searchresult: Tools
This page presents information tools that can be helpful for all areas of the scientific communication process and for which DKFZ employees have a license to use. These are, for example, literature…
-
Searchresult: Functional and Structural Genomics
Our Research Topic For cancer to arise, multiple molecular changes need to happen in a cell. This Research Topic aims to molecularly characterize these changes in a comprehensive manner, at multiple…
-
Searchresult: PANHPVAX-Studie
-
Searchresult: Aushang_PANHPVAX_de.pdf
PANHPVAX-Studie – Impfung gegen Humane Papillomviren Probandinnen und Probanden gesucht Die klinische Phase-I-Studie untersucht bei gesunden Probanden die Sicherheit, Verträglichkeit und…
Document -
Searchresult: Aushang_PANHPVAX_en.pdf
PANHPVAX study – vaccination against human papillomaviruses Healthy volunteers wanted The clinical phase I study is assessing the safety, tolerability and immunogenicity of a novel vaccine…
Document